False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.

MLA

Takasu, Nobuyuki, et al. “False-Positive 123I-Metaiodobenzylguanidine (MIBG) Scan in a Patient with Angiomyolipoma; Positive MIBG Scan Does Not Necessarily Indicate the Presence of Pheochromocytoma.” Internal Medicine (Tokyo, Japan), vol. 46, no. 20, 2007, pp. 1717–21. EBSCOhost, https://doi.org/10.2169/internalmedicine.46.0232.

APA

Takasu, N., Hayashi, M., Takara, M., Iha, T., Kouki, T., Ohshiro, Y., & Ogawa, Y. (2007). False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma. Internal Medicine (Tokyo, Japan), 46(20), 1717–1721. https://doi.org/10.2169/internalmedicine.46.0232

Chicago

Takasu, Nobuyuki, Mina Hayashi, Masaki Takara, Takako Iha, Tsuyoshi Kouki, Yuzuru Ohshiro, and Yoshihide Ogawa. 2007. “False-Positive 123I-Metaiodobenzylguanidine (MIBG) Scan in a Patient with Angiomyolipoma; Positive MIBG Scan Does Not Necessarily Indicate the Presence of Pheochromocytoma.” Internal Medicine (Tokyo, Japan) 46 (20): 1717–21. doi:10.2169/internalmedicine.46.0232.